Adjunctive Esketamine for Analgesia in Mechanically Ventilated Septic Shock Patients
Septic Shock, Mechanical Ventilation Complication
About this trial
This is an interventional treatment trial for Septic Shock focused on measuring Esketamine, Vasoactive drugs, sedation, analgesia
Eligibility Criteria
Inclusion Criteria: Age ≥ 18; A patient diagnosed with septic shock; It needs to be treated with analgesics, sedatives, and vasopressors for a period of not less than 48 hours; Mechanical ventilation by the ventilator is needed; Obtain the informed consent of the human subjects or their legal representatives; Exclusion Criteria: Pregnant patient The patient had acute coronary syndrome, NYHA grade IV, or refractory heart failure; Any other condition that may seriously interfere with the collection of research data, such as loss of hearing or vision; any allergic reaction to any of the research drugs; The clinician determines that a patient who is unlikely to be separated from mechanical ventilation, such as a disease/injury that primarily affects the neuromuscular function of the respirator and an apparently irreversible disease requiring long-term ventilation support (such as high spinal cord injury); The researcher judged that it was not suitable to participate in the study;
Sites / Locations
- Southern medical university Nanfang hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Remifentanil + propofol + esketamine
remifentanil + propofol + saline
esketamine (2ml; 50mg), Remifentanil Hydrochloride for Injection (1mg;), propofol injection (50ml; 0.5g; ); The frequency of use is determined by responsible clinicians.All analgesic and sedative drugs used are adjusted according to the actual situation of the patient.
Remifentanil Hydrochloride for Injection (1mg;), propofol injection (50ml; 0.5g; ); The amount of saline used is equivalent to the amount of esketamine.All analgesic and sedative drugs used are adjusted according to the actual situation of the